Human insulin biosimilar (Marvel Lifesciences)
人胰岛素生物类似药 (Marvel Lifesciences)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman insulin biosimilar (Marvel Lifesciences)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesMarvel Lifesciences Pte Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesMarvel Lifesciences Pte Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code +[5]
Related LinksN/A